Publons CV

Prepared by Publons on May 28th 2022

Nazia Chaudhuri
https://publons.com/researcher/J-4517-2019/
Web of Science ResearcherID: J-4517-2019

Current affiliations:
- Manchester University NHS Foundation Trust from 2012 until present
- University of Manchester from 2012 until present

Publications
PUBLISHING SUMMARY

(34) Thorax (31) European Respiratory Journal

(12) American Journal of Respiratory and Critical Care Medicine (8) Journal of Clinical Medicine

(4) Advances in Therapy (3) BMJ Open Respiratory Research

(3) Lung Cancer (2) Respiratory Medicine

(2) Journal of Thoracic Disease (2) JACC: Journal of the American College of Cardiology

(2) The Lancet Respiratory Medicine (2) European Respiratory Review

(2) ERJ Open Research (2) Sarcoidosis Vasculitis and Diffuse Lung Diseases

(2) The Lancet (1) Drugs & Aging

(1) British Journal of General Practice (1) Clinical and Translational Medicine

(1) QJM - Monthly Journal of the Association of Physicians (1) Plos One

(1) American Journal of Physiology-Lung Cellular and Molecular Physiology (1) Paediatric Respiratory Reviews

(1) Chest (1) Clinical Science

(1) Therapeutic Advances in Respiratory Disease (1) Respiration

(1) Respiratory Research (1) New England Journal of Medicine

(1) Journal of Leukocyte Biology (1) Annals of the Rheumatic Diseases

(1) Clinical Medicine Insights: Therapeutics (1) International Journal of Audiology

(1) Expert Review of Respiratory Medicine (1) International Journal of Cardiovascular Imaging

(1) JACC: Cardiovascular Imaging (1) British Thoracic Society Winter Meeting

(1) Pulmonary Therapy (1) Frontiers in Medicine

 (1) Pneumologie (1) Trials

(1) Rheumatology

MANUSCRIPTS PUBLISHED (137)

Rheumatologists have an important role in the management of interstitial lung disease (ILD):
a cross-speciality, multi-centre, UK perspective
Published in Rheumatology

PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine

sulphate for the treatment of pulmonary Fibrosis Cough
Published in Trials

Treatment of fibrotic interstitial lung disease: current approaches and future directions
Published in The Lancet

Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and

Non-specialised ILD Centres Around the World
Published in Frontiers in Medicine

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung
Disease-Long COVID Study (UKILD-Long COVID)
Published in BMJ Open Respiratory Research

Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a

COVID Follow-Up Service
Published in Advances in Therapy

The burden of Progressive Fibrotic Interstitial lung disease across the UK

Published in European Respiratory Journal

Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial
Published in European Respiratory Journal

Pulmonary Therapy Podcast-COVID-19: Research and Real-World Experiences from the

Editorial Board
Published in Pulmonary Therapy

Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive
Fibrosing Interstitial Lung Diseases (ILDs) by GAP Stage
Published in American Journal of Respiratory and Critical Care Medicine

Myocardial involvement in eosinophilic granulomatosis with polyangiitis evaluated with

cardiopulmonary magnetic resonance
Published in International Journal of Cardiovascular Imaging
Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing
ILDs treated with DMARDs or glucocorticoids?
Published in Pneumologie

Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential
Role for Aerodigestive Pathophysiology? Reply
Published in American Journal of Respiratory and Critical Care Medicine

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised,

controlled, open-label, platform trial
Published in The Lancet

Substrate for the Myocardial Inflammation Heart Failure Hypothesis Identified Using Novel
USPIO Methodology
Published in JACC: Cardiovascular Imaging

P168 Patient symptoms following discharge from hospital after COVID-19 Pneumonia
Published in British Thoracic Society Winter Meeting

Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic
registry between 2013 and 2019
Published in ERJ Open Research

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease An

International Multicenter Study
Published in American Journal of Respiratory and Critical Care Medicine

Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19

cases
Published in International Journal of Audiology

Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary
Fibrosis with Preserved Lung Function on Antifibrotic Treatment
Published in Advances in Therapy

The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease
Published in Expert Review of Respiratory Medicine

Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease

Published in European Respiratory Journal

Does nintedanib have the same effect on FVC decline in patients with progressive fibrosing
ILDs treated with DMARDs or glucocorticoids?
Published in European Respiratory Journal

Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease

progression
Published in European Respiratory Journal
REAL WORLD EXPERIENCE OF RESPONSE TO PIRFENIDONE IN PATIENTS WITH
IDIOPATHIC PULMONARY FIBROSIS: A TWO CENTRE RETROSPECTIVE STUDY
Published in Sarcoidosis Vasculitis and Diffuse Lung Diseases

RAPIDLY NON-IPF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE: A

PHENOTYPE WITH AN IPF-LIKE BEHAVIOR
Published in Sarcoidosis Vasculitis and Diffuse Lung Diseases

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup

analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-
blind, placebo-controlled, parallel-group trial
Published in The Lancet Respiratory Medicine

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for
harmonisation
Published in European Respiratory Journal

How consistently do physicians diagnose and manage drug-induced interstitial lung

disease? Two surveys of European ILD specialist physicians
Published in ERJ Open Research

The QRISK-2 Score Identifies an Increased Cardiovascular Risk in Patients with Idiopathic
Pulmonary Fibrosis at Time of Diagnosis
Published in American Journal of Respiratory and Critical Care Medicine

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for

Potential Adverse Events
Published in Respiration

Identifying causation in hypersensitivity pneumonitis: a British perspective

Published in BMJ Open Respiratory Research

WHAT HAPPENS TO PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS WHO ARE NOT
ELIGIBLE FOR ANTIFIBROTIC TREATMENT DUE TO CURRENT NICE GUIDELINES
Published in Thorax

QUANTITATIVE CT AND HYPERPOLARISED 129-XENON DIFFUSION-WEIGHTED MRI IN

INTERSTITIAL LUNG DISEASE
Published in Thorax

Comment from the Editor of the Special Issue: "Lung Disease on COPD, Asthma,
Bronchiectasis, Lung Cancer Screening, IPF"
Published in Journal of Clinical Medicine

Beware Weakening the Ivory Tower of MDT Diagnosis in Interstitial Lung Disease
Published in Journal of Clinical Medicine
Comment from the Editor of the Special Issue: "Lung Disease on COPD, Asthma,
Bronchiectasis, Lung Cancer Screening, IPF"
Published in Journal of Clinical Medicine

Beware Weakening the Ivory Tower of MDT Diagnosis in Interstitial Lung Disease
Published in Journal of Clinical Medicine

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Published in New England Journal of Medicine

The therapy of idiopathic pulmonary fibrosis: what is next?

Published in European Respiratory Review

Adherence to home spirometry among patients with IPF: results from the INMARK trial
Published in European Respiratory Journal

Safety and tolerability of immunosuppression in non-IPF ILD: clinical experience from a

tertiary ILD centre
Published in European Respiratory Journal

Interstitial lung disease associated with ANCA positivity: a retrospective analysis

Published in European Respiratory Journal

Predictive variables to obtain a bronehoalveolar lavage of adequate quality in patients with

interstitial lung diseases
Published in European Respiratory Journal

Association of demographic, laboratory and clinical parameters with HRCT-chest findings in

patients with sarcoidosis
Published in European Respiratory Journal

The therapy of idiopathic pulmonary fibrosis: what is next? (vol 28, 190021, 2019)
Published in European Respiratory Review

The importance of real-life research in respiratory medicine: manifesto of the Respiratory

Effectiveness Group
Published in European Respiratory Journal

Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review
Published in Advances in Therapy

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis

given nintedanib (INMARK study): a randomised, placebo-controlled study
Published in The Lancet Respiratory Medicine

INTERSTITIAL LUNG DISEASE ASSOCIATED WITH ANCA POSITIVITY: A RETROSPECTIVE

ANALYSIS
Published in Annals of the Rheumatic Diseases
Differences in the Approach to Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE IPF)
Between Expert Centres and General Pulmonologists: Results from an International Survey
Published in American Journal of Respiratory and Critical Care Medicine

THE ASSOCIATION OF CARDIOVASCULAR DISEASE WITH RESPIRATORY DISEASE AND

IMPACT ON MORTALITY
Published in JACC: Journal of the American College of Cardiology

Sarcoidosis in the UK: insights from British Thoracic Society registry data
Published in BMJ Open Respiratory Research

No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone

Published in European Respiratory Journal

Prevalence of incidental interstitial lung disease in the Manchester lung cancer screening
pilot
Published in Lung Cancer

Longitudinal change in hyperpolarised 129-xenon MR spectroscopy in interstitial lung

disease
Published in European Respiratory Journal

Hyperpolarised 129-xenon diffusion-weighted MRI in interstitial lung disease

Published in European Respiratory Journal

Treatment of severe idiopathic pulmonary fibrosis-is sildenafil the next (in)stage?

Published in Journal of Thoracic Disease

Association of Cardiovascular Disease With Respiratory Disease

Published in JACC: Journal of the American College of Cardiology

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review

Published in Respiratory Research

Drug-Induced Interstitial Lung Disease: A Systematic Review

Published in Journal of Clinical Medicine

Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and
real-world experience
Published in Therapeutic Advances in Respiratory Disease

The impact of a network based approach on lung function and symptom duration at
diagnosis in idiopathic pulmonary fibrosis
Published in European Respiratory Journal

Breath Biomarkers in Idiopathic Pulmonary Fibrosis: A Systematic Review

Published in European Respiratory Journal
What can we learn from Idiopathic Pulmonary Fibrosis Registries?
Published in European Respiratory Journal

Drug induced interstitial lung disease: a systematic review

Published in European Respiratory Journal

Antifibrotic choice in idiopathic pulmonary fibrosis

Published in European Respiratory Journal

Introducing a new formulation of pirfenidone to reduce tablet burden for the IPF patient: Is it
tolerable? Is it easy to take? What do our patients think?
Published in European Respiratory Journal

A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results

from an international survey
Published in European Respiratory Journal

Idiopathic pulmonary fibrosis: a clinical update

Published in British Journal of General Practice

Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung

Disease (ILD)
Published in Respiratory Medicine

Idiopathic Pulmonary Fibrosis (IPF): An Overview

Published in Journal of Clinical Medicine

Peripheral Eosinophilia in Idiopathic Pulmonary Fibrosis - Are There Clinical Implications? A

Retrospective Cohort Study of Patients Commencing Antifibrotic Therapy
Published in American Journal of Respiratory and Critical Care Medicine

No Relevant Pharmacokinetic Interaction Between Nintedanib and Pirfenidone in Patients

with Idiopathic Pulmonary Fibrosis (IPF): Results from a Drug-Drug Interaction Study
Published in American Journal of Respiratory and Critical Care Medicine

DO ANTIFIBROTICS IMPACT ON LUNG TRANSPLANTATION OUTCOMES IN IDIOPATHIC

PULMONARY FIBROSIS?
Published in Thorax

IDIOPATHIC PULMONARY FIBROSIS: "LOST IN THE SYSTEM" IN THE NORTH WEST OF

ENGLAND?
Published in Thorax

CAN BASELINE PHYSIOLOGICAL TESTS HELP PREDICT THE OUTCOME OF HYPOXIC

CHALLENGE TESTING (HCT) IN INTERSTITIAL LUNG DISEASE (ILD)?
Published in Thorax
THE ROLE OF BRONCHOALVEOLAR LAVAGE AND ITS QUALITY IN THE DIAGNOSIS OF
INTERSTITIAL LUNG DISEASE
Published in Thorax

Idiopathic pulmonary fibrosis: a holistic approach to disease management in the antifibrotic

age
Published in Journal of Thoracic Disease

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international

case-cohort study
Published in European Respiratory Journal

Bagpipe lung; a new type of interstitial lung disease?

Published in Thorax

Feather bedding as a cause of hypersensitivity pneumonitis

Published in QJM - Monthly Journal of the Association of Physicians

Current Treatments in the Management of Idiopathic Pulmonary Fibrosis: Pirfenidone and

Nintedanib
Published in Clinical Medicine Insights: Therapeutics

Managing Idiopathic Pulmonary Fibrosis: Which Drug for Which Patient?

Published in Drugs & Aging

Five Years Of Real World Pirfenidone Experience

Published in American Journal of Respiratory and Critical Care Medicine

Clinical Experience With Nintedanib For Idiopathic Pulmonary Fibrosis In 3 Uk Tertiary

Interstitial Lung Disease Centres
Published in American Journal of Respiratory and Critical Care Medicine

Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
Published in Clinical and Translational Medicine

First Insights from the BTS Idiopathic Pulmonary Fibrosis (IPF) registry
Published in European Respiratory Journal

Sarcoidosis in the UK: Insights from the BTS interstitial lung disease registry
Published in European Respiratory Journal

Clinical experience with nintedanib for IPF in 3 UK tertiary referral centres

Published in European Respiratory Journal

A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: A Retrospective

Analysis in a Single UK Specialist Centre
Published in Journal of Clinical Medicine
Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated
Treatments for Idiopathic Pulmonary Fibrosis
Published in Journal of Clinical Medicine

A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY TO ASSESS

THE EFFICACY OF A SINGLE DOSE OF 100 MG OF VRP700 BY INHALATION IN REDUCING
THE FREQUENCY AND SEVERITY OF COUGH IN ADULT PATIENTS WITH IDIOPATHIC
PULMONARY FIBROSIS
Published in Thorax

SARCOIDOSIS AND CO-EXISTENT ASPERGILLUS LUNG DISEASE

Published in Thorax

EARLY CLINICAL EXPERIENCE WITH NINTEDANIB A TWO CENTRE REVIEW

Published in Thorax

REAL WORLD MDT DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS

Published in Thorax

IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Published in European Respiratory Journal

IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with
Pirfenidone in Europe
Published in Advances in Therapy

COST BURDEN OF N-ACETYLCYSTEINE (NAC) IN ADULT PATIENTS WITH IDIOPATHIC

PULMONARY FIBROSIS
Published in Thorax

A QUARTER OF IPF PATIENTS NOT ELIGIBLE FOR PIRFENIDONE TREATMENT DUE TO THE
NICE CRITERIA SIGNIFICANTLY DECLINE OVER TIME
Published in Thorax

HEALTH AND ECONOMIC IMPACT OF PRESCRIBING PIRFENIDONE

Published in Thorax

EXTENDED CLINICAL EXPERIENCE WITH PIRFENIDONE DURING A NAMED PATIENT

PROGRAMME FOR IDIOPATHIC PULMONARY FIBROSIS (IPF): INTERIM RESULTS
Published in Thorax

Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary
fibrosis
Published in Respiratory Medicine

Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific

interstitial pneumonitis (NSIP)
Published in European Respiratory Journal
Evolution of an interstitial lung disease MDT: 5.5 years of data
Published in European Respiratory Journal

Real World Experiences: Pirfenidone Is Well Tolerated In Patients With Idiopathic Pulmonary
Fibrosis
Published in American Journal of Respiratory and Critical Care Medicine

INTERSTITIAL LUNG DISEASE MULTIDISCIPLINARY DISCUSSION: SIX YEARS OF DATA

FROM A TERTIARY SERVICE
Published in Thorax

THE CREATION OF A SIMULATED PAN-DEANERY MEDICAL THORACOSCOPY AND

INDWELLING PLEURAL CATHETER COURSE
Published in Thorax

SOLE USE OF FORCED VITAL CAPACITY AS PER NATIONAL INSTITUTE OF HEALTH AND
CARE EXCELLENCE CRITERIA DISADVANTAGE 2 IN 5 PEOPLE WITH IDIOPATHIC
PULMONARY FIBROSIS
Published in Thorax

British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited
by NICE
Published in Thorax

Summary of the British Thoracic Society guideline for diagnostic flexible bronchoscopy in
adults
Published in Thorax

Unilateral small pleural effusions adjacent to primary lung tumours - malignant or reactive?
Published in Lung Cancer

Real World experiences: Pirfenidone is well tolerated and reduces decline in FVC and TLCO
at 9 months in IPF
Published in European Respiratory Journal

Change in LDH assay can affect classification of pleural effusions using Light's criteria
Published in European Respiratory Journal

Diesel Exhaust Particle Exposure In Vitro Alters Monocyte Differentiation and Function
Published in Plos One

CHRONIC DIESEL EXHAUST PARTICLE (DEP) EXPOSURE DIFFERENTIALLY ALTERS

MONOCYTE DIFFERENTIATION AND FUNCTION IN HEALTHY CONTROLS COMPARED TO
COPD
Published in Thorax

Diesel exhaust particles override natural injury-limiting pathways in the lung

Published in American Journal of Physiology-Lung Cellular and Molecular Physiology
DIESEL EXHAUST PARTICLES ALTER MONOCYTE DIFFERENTIATION IN VITRO BUT HAVE
LITTLE IMPACT ON NEUTROPHIL FUNCTION
Published in Thorax

Diesel Exhaust Particles Alter Monocyte Differentiation In Vitro

Published in American Journal of Respiratory and Critical Care Medicine

The Role of Cell Networks in Response to Diesel Exhaust Particles

Published in American Journal of Respiratory and Critical Care Medicine

DIESEL EXHAUST PARTICLES POTENTIATE INFLAMMATION AND RENDER IT RESISTANT

TO IL-1 ANTAGONISM IN VITRO
Published in Thorax

Basic science of the innate immune system and the lung

Published in Paediatric Respiratory Reviews

Survival and treatment of mesothelioma cases in Sheffield, UK from Sep 1998 to Mar 2006
Published in Lung Cancer

Reducing the toll of inflammatory lung disease

Published in Chest

The role of Cell networks in the response to Diesel Exhaust Particles (DEP)
Published in Journal of Leukocyte Biology

Effect of training on patient outcomes following lobectomy

Published in Thorax

The management of spontaneous pneumothorax: Are we adhering to British thoracic

society guidelines?
Published in Thorax

Toll-like receptors and chronic lung disease

Published in Clinical Science

The third wave: An updated meta-analysis of postoperative chemotherapy for non-small cell
lung cancer using cisplatin based regimens
Published in Thorax

Preoperative predictors of prolonged air leak following lobectomy for primary lung cancer
Published in Thorax

Contemporary use of a prospective computerised database in thoracic surgery: Patient and

practice management aspects
Published in Thorax

Is atrial fibrillation after lung resection dependent on the extent of resection?

Published in Thorax
Bronchial carcinoid tumours: Surgical management and long term outcome
Published in Thorax

Does surgical outcome for resection of lung cancer depend on surgeons attending MDTs?
Published in Thorax

Immunohistochemical prognostic markers in malignant mesothelioma

Published in Thorax

Ex-vivo isolated, perfused human lung model: Description and effect of endothelin agonists
Published in Thorax

Prediction of "non-tumour" related complications after chest wall resection for non small cell
lung cancer
Published in Thorax

Verified reviews
REVIEW SUMMARY

REVIEWER SUMMARY

(16) Advances in Therapy (10) Pulmonary Therapy

(8) Therapeutic Advances in Respiratory Disease (8) BMC Pulmonary Medicine

(8) Journal of Clinical Medicine (7) Expert Review of Respiratory Medicine

(6) Respirology (6) Respiration

(5) Respiratory Research (5) Respiratory Medicine

(4) Journal of International Medical Research (4) Journal of Thoracic Disease

(4) International Journal of Molecular Sciences (3) BMJ Open Respiratory Research

(3) European Respiratory Journal (3) Chronic Respiratory Disease

(2) Frontiers in Medicine (2) BJGP Open

(2) Drug Design, Development and Therapy (2) Plos One

 (2) American Journal of Respiratory and Critical Care Medicine (2) Drug Safety

(2) Clinical and Translational Medicine (2) Annals of the American Thoracic Society

(1) Sarcoidosis Vasculitis and Diffuse Lung Diseases (1) EClinicalMedicine

(1) Clinical Case Reports (1) BMJ Case Reports

(1) Chest (1) European Respiratory Review

(1) British Journal of Clinical Pharmacology (1) Therapeutics and Clinical Risk Management

(1) Journal of Cardiothoracic Surgery (1) Targeted Oncology

(1) BMJ Supportive & Palliative Care (1) Expert Review of Clinical Immunology

(1) Archivos de Bronconeumologia (1) Patient Preference and Adherence

(1) Thorax (1) ClinicoEconomics and Outcomes Research

(1) BMJ (1) ERJ Open Research

(1) Annals of Translational Medicine (1) Cancers

(1) International Journal of Environmental Research and Public Health

137 REVIEWS OF 114 MANUSCRIPTS

-
Reviewed: Feb 2022 for Sarcoidosis Vasculitis and Diffuse Lung Diseases

-
Reviewed: Feb 2022 for EClinicalMedicine

-
Reviewed: Feb 2022 for Frontiers in Medicine

-
Reviewed: Feb 2022 for BMC Pulmonary Medicine

-
2 rounds from Dec 2021 to Feb 2022 for Respiratory Research

-
Reviewed: Jan 2022 for BMJ Open Respiratory Research

-
Reviewed: Dec 2021 for Clinical Case Reports

-
Reviewed: Dec 2021 for Therapeutic Advances in Respiratory Disease

-
Reviewed: Dec 2021 for BMJ Case Reports

-
Reviewed: Oct 2021 for European Respiratory Journal

-
2 rounds from May 2021 to Jun 2021 for BJGP Open
-
Reviewed: May 2021 for Chest

-
2 rounds from Apr 2021 to May 2021 for Journal of Clinical Medicine

-
Reviewed: May 2021 for Therapeutic Advances in Respiratory Disease

-
Reviewed: May 2021 for Expert Review of Respiratory Medicine

-
Reviewed: Apr 2021 for Expert Review of Respiratory Medicine

-
Reviewed: Apr 2021 for Advances in Therapy

-
Reviewed: Mar 2021 for Therapeutic Advances in Respiratory Disease

-
Reviewed: Mar 2021 for Expert Review of Respiratory Medicine

-
Reviewed: Mar 2021 for Advances in Therapy

-
2 rounds from Feb 2021 to Feb 2021 for Pulmonary Therapy

-
Reviewed: Feb 2021 for BMJ Open Respiratory Research

-
2 rounds from Dec 2020 to Feb 2021 for American Journal of Respiratory and Critical Care Medicine

-
2 rounds from Nov 2020 to Feb 2021 for Respiration

-
Reviewed: Feb 2021 for Journal of International Medical Research

-
2 rounds from Nov 2020 to Dec 2020 for Plos One

-
Reviewed: Dec 2020 for Frontiers in Medicine

-
Reviewed: Nov 2020 for Therapeutic Advances in Respiratory Disease

-
2 rounds from Sep 2020 to Nov 2020 for Journal of Clinical Medicine

-
Reviewed: Nov 2020 for BMJ Open Respiratory Research

-
Reviewed: Nov 2020 for European Respiratory Journal
-
Reviewed: Oct 2020 for Respiration

-
Reviewed: Sep 2020 for Advances in Therapy

-
Reviewed: Jul 2020 for Archivos de Bronconeumologia

-
Reviewed: Mar 2020 for Journal of Clinical Medicine

-
Reviewed: Mar 2020 for Advances in Therapy

-
Reviewed: Feb 2020 for Expert Review of Clinical Immunology

-
Reviewed: Feb 2020 for Journal of Clinical Medicine

-
Reviewed: Feb 2020 for Advances in Therapy

-
2 rounds from Feb 2020 to Feb 2020 for Drug Safety

-
Reviewed: Feb 2020 for Advances in Therapy

-
Reviewed: Jan 2020 for Advances in Therapy

-
2 rounds from Oct 2019 to Jan 2020 for Therapeutic Advances in Respiratory Disease

-
Reviewed: Jan 2020 for European Respiratory Journal

-
Reviewed: Dec 2019 for Journal of International Medical Research

-
Reviewed: Dec 2019 for Therapeutic Advances in Respiratory Disease

-
Reviewed: Dec 2019 for Expert Review of Respiratory Medicine

-
Reviewed: Dec 2019 for Respiratory Research

-
Reviewed: Nov 2019 for Therapeutic Advances in Respiratory Disease

-
Reviewed: Nov 2019 for Annals of the American Thoracic Society

-
Reviewed: Nov 2019 for Journal of Cardiothoracic Surgery
-
Reviewed: Nov 2019 for Respiratory Research

-
Reviewed: Nov 2019 for Respiratory Medicine

-
Reviewed: Oct 2019 for Respirology

-
Reviewed: Sep 2019 for Respiratory Research

-
3 rounds from Dec 2018 to Sep 2019 for BMC Pulmonary Medicine

-
Reviewed: Aug 2019 for ERJ Open Research

-
2 rounds from Jul 2019 to Jul 2019 for Advances in Therapy

-
2 rounds from Feb 2019 to Jul 2019 for BMC Pulmonary Medicine

-
Reviewed: May 2019 for Respiratory Medicine

-
Reviewed: May 2019 for Chronic Respiratory Disease

-
Reviewed: May 2019 for Targeted Oncology

-
2 rounds from Feb 2019 to May 2019 for Expert Review of Respiratory Medicine

-
Reviewed: May 2019 for Advances in Therapy

-
Reviewed: Apr 2019 for Advances in Therapy

-
Reviewed: Feb 2019 for Advances in Therapy

-
Reviewed: Nov 2018 for Advances in Therapy

-
Reviewed: Feb 2016 for Advances in Therapy

-
Reviewed: May 2019 for Pulmonary Therapy

-
Reviewed: Jan 2019 for Pulmonary Therapy

-
Reviewed: Mar 2018 for Pulmonary Therapy
-
Reviewed: Jul 2017 for Pulmonary Therapy

-
2 rounds from Apr 2019 to Apr 2019 for Journal of Clinical Medicine

-
Reviewed: Apr 2019 for British Journal of Clinical Pharmacology

-
Reviewed: Apr 2019 for Chronic Respiratory Disease

-
Reviewed: Mar 2019 for Patient Preference and Adherence

-
Reviewed: Mar 2019 for Annals of Translational Medicine

-
Reviewed: Mar 2019 for Chronic Respiratory Disease

-
Reviewed: Mar 2019 for Respiration

-
Reviewed: Mar 2019 for Journal of Thoracic Disease

-
Reviewed: Mar 2019 for European Respiratory Review

-
Reviewed: Feb 2019 for Thorax

-
Reviewed: Dec 2018 for International Journal of Environmental Research and Public Health

-
Reviewed: Nov 2018 for Advances in Therapy

-
Reviewed: Nov 2018 for Respiratory Medicine

-
Reviewed: Nov 2018 for Annals of the American Thoracic Society

-
2 rounds from Sep 2018 to Nov 2018 for International Journal of Molecular Sciences

-
Reviewed: Nov 2018 for Advances in Therapy

-
Reviewed: Oct 2018 for Clinical and Translational Medicine

-
Reviewed: Oct 2018 for Clinical and Translational Medicine

-
2 rounds from Jul 2018 to Sep 2018 for BMC Pulmonary Medicine
-
Reviewed: Jul 2018 for International Journal of Molecular Sciences

-
Reviewed: Jun 2018 for Journal of Thoracic Disease

-
2 rounds from May 2018 to Jun 2018 for Respirology

-
Reviewed: Jun 2018 for Cancers

-
2 rounds from Feb 2018 to May 2018 for Respiration

-
Reviewed: Apr 2018 for Journal of Thoracic Disease

-
Reviewed: Mar 2018 for Pulmonary Therapy

-
Reviewed: Feb 2018 for Pulmonary Therapy

-
Reviewed: Nov 2017 for ClinicoEconomics and Outcomes Research

-
Reviewed: Oct 2017 for International Journal of Molecular Sciences

-
2 rounds from Aug 2017 to Oct 2017 for Respiratory Medicine

-
Reviewed: Sep 2017 for Journal of Thoracic Disease

-
Reviewed: Jul 2017 for Pulmonary Therapy

-
2 rounds from May 2017 to May 2017 for Journal of International Medical Research

-
Reviewed: May 2017 for Respirology

-
Reviewed: Jan 2017 for BMJ Supportive & Palliative Care

-
Reviewed: Nov 2016 for Drug Design, Development and Therapy

-
2 rounds from Sep 2016 to Nov 2016 for Respirology

-
Reviewed: Jul 2016 for Expert Review of Respiratory Medicine

-
Reviewed: Nov 2015 for Therapeutics and Clinical Risk Management
-
Reviewed: Oct 2015 for Pulmonary Therapy

-
Reviewed: Mar 2015 for Drug Design, Development and Therapy

-
Reviewed: Jan 2015 for BMJ

Editor records
EDITOR SUMMARY

(26) Journal of Clinical Medicine

MANUSCRIPTS HANDLED AS EDITOR (26)

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine

For: Journal of Clinical Medicine